Patent holdings for IPC class C07D 221/02

Total number of patents in this class: 101

10-year publication summary

6
4
4
2
2
6
1
6
5
3
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Theravance Biopharma R&D IP, LLC
457
7
Merck Sharp & Dohme LLC
3732
7
Bristol-myers Squibb Company
4845
3
Purdue Research Foundation
3691
3
CalciMedica, Inc.
92
3
Merck Sharp & Dohme Corp.
2190
2
Boehringer Ingelheim International GmbH
4641
2
Massachusetts Institute of Technology
10127
2
Biosearch Technologies, Inc.
63
2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
708
2
Jiangsu Vcare PharmaTech Co., Ltd.
35
2
Nippon Soda Co., Ltd.
891
2
Rothamsted Research Limited
62
2
Wild Flavors, Inc.
31
2
Sanofi
4109
2
Awakn LS Europe Holdings Limited
14
2
Glaxo Group Limited
4139
1
The Regents of the University of California
20172
1
Merck & Co., Inc.
291
1
Boehringer Ingelheim Vetmedica GmbH
1276
1
Other owners 52